NCT03547141View on ClinicalTrials.gov

Pharmacodynamic and Safety of MBA-P01 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

April 16, 2018

Primary Completion Date

August 28, 2018

Study Completion Date

November 1, 2018

Conditions
Healthy
Interventions
DRUG

MBA-P01

injection of MBA-P01 into the muscle of each contralateral foot in equal doses

DRUG

BOTOX

injection of BOTOX into the muscle of each contralateral foot in equal doses

Trial Locations (1)

Unknown

The Catholic University of Korea, St. Paul's Hospital, Seoul

All Listed Sponsors
lead

Medy-Tox

INDUSTRY

NCT03547141 - Pharmacodynamic and Safety of MBA-P01 in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter